Note: Ingredients listed on restricted chemical lists
EC/CAS
258-904-8/53988-10-6
Name of the chemical
1,3-dihydro-4(or 5)-methyl-2H-benzimidazole-2-thione
Concentration
99%
General Information
Revision date
2015-07-27
Product name
Ekaland MMBI PD
Substance name
Ekaland MMBI PD
CAS No.
53988-10-6
REACH No
The
1.2.1 Relevant identified uses
Antioxidant
supplier name
MLPC International
Emergency telephone
+44 (0) 1235 239 670 (Carechem24 – MLPC 29003) Europe
Icons in SDS
Company Information
company name
MLPC International
e-mail address of the competent person responsible for the Safety Data Sheet
fds@mlpc-intl.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H302+H332, H332, H361f, H361fd, H373, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Oral: Acute toxicity, 4, H302 Inhalation: Acute toxicity, 4, H332 Reproductive toxicity, 2, H361fd Specific target organ toxicity - repeated exposure, 2, H373 Chronic aquatic toxicity, 1, H410
Additional information
For the full text of the H, EUH-phrases mentioned in this Section, see Section 16.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Hazardous Ingredients
CAS-No. : 53988-10-6 1,3-Dihydro-4(or 5)-methyl-2H-benzimidazole-2-thione
Signal word
Warning
Hazard statements
H302 + H332 : Harmful if swallowed or if inhaled H361f : Suspected of damaging fertility. H373 : May cause damage to organs through prolonged or repeated exposure if swallowed. H410 : Very toxic to aquatic life with long lasting effects.
Prevention
P260 : Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P281 : Use personal protective equipment as required.
Response
P312 : Call a POISON CENTER or doctor/ physician if you feel unwell. P314 : Get medical advice/ attention if you feel unwell.
Storage
P403 + P233 : Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 : Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
None Other:
Results of PBT and vPvB assessment
According to REACH regulation, annex XIII, the substance does not meet PBT and vPvB criteria
